Insulet (PODD) FY2016 results: revenue $367 million, up 39.1% on the year
Insulet Corp. (PODD) reported revenue of $367 million for fiscal 2016, the year ended 31 December 2016, up 39.1% on the year before. Net income was -$29 million, and diluted earnings per share $-0.48. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2017.
Revenue
$367 million
+39.1% on the year
FY2009FY2016
Operating margin
-2.9%
-18.5% a year earlier
FY2009FY2016
Net income
-$29 million
FY2009FY2016
Diluted EPS
-$0.48
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
367
264
231
+39.1%
Cost of revenue
156
131
104
+19.4%
Gross profit
211
133
127
+58.4%
Gross margin
57.5%
50.5%
55.0%
Research and development
55.7
43.2
27.9
+28.9%
Operating income
-10.7
-48.7
-8.9
Operating margin
-2.9%
-18.5%
-3.8%
Interest expense
14.4
12.7
14.6
+13.2%
Pre-tax income
-26.8
-61.4
-47.9
Income tax
0.4
0.2
0.1
+84.9%
Net income
-28.9
-73.5
-51.5
Net margin
-7.9%
-27.9%
-22.3%
Diluted EPS
-$0.48
-$1.29
-$0.93
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
15.9
-12.6
8.9
Capital expenditure
22.1
10.6
11.5
+108.5%
Free cash flow
-6.2
-23.2
-2.6
Free cash flow margin
-1.7%
-8.8%
-1.1%
Cash from investing
-178
-15.3
-11.5
Cash from financing
177
-0.4
4.0
Depreciation and amortisation
13.8
15.8
12.2
-12.7%
Share-based compensation
23.6
19.2
22.5
+23.1%
Diluted shares, weighted
57m
n/a
n/a
Shares outstanding at period end
57m
57m
56m
+1.0%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
63.1
34.1
83.8
+85.5%
Debt
333
172
164
+93.8%
Other liabilities
60.7
69.4
49.3
-12.5%
Total liabilities and equity
457
275
297
+66.0%
Fixed assets
44.8
41.8
36.9
+7.1%
Goodwill
39.7
39.6
37.4
+0.2%
Intangible assets
2.0
0.9
0.0
+118.8%
Investments
161
0.0
n/a
Cash and equivalents
137
123
151
+11.8%
Receivables
28.8
42.5
35.2
-32.3%
Inventory
35.5
12.0
11.4
+195.4%
Other assets
7.3
15.6
25.0
-53.2%
Total assets
457
275
297
+66.0%
10-K for the year ended 31 December 2016, filed 28 February 2017: the filing.